Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
The Oncologist|May 4, 2021
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaHani Babiker, Irene Brana, Daruka Mahadevan, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2018
Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)Kristina Lindemann, Philip J Beale, Emma Rossi, et al.
Social Science & Medicine (1982)|November 15, 2020
Cluster randomized controlled trial of volitional and motivational interventions to improve bowel cancer screening uptake: A population-level studySarah Wilding, Anastasia Tsipa, Dawn Branley-Bell, et al.
Targeted Oncology|May 27, 2014
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancerFiona Day, Andrea Muranyi, Shalini Singh, et al.
Asia-Pacific Journal of Clinical Oncology|March 21, 2024
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic diseaseFiona Day, Swetha Sridharan, Catherine Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]J Simon W Stewart, Ezra E W Cohen, Lisa Licitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumorsPatricia M LoRusso, Roy S Herbst, Danny Rischin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 studyMakoto Tahara, Richard Greil, Danny Rischin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancerDariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 10, 2025
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative StudyJohn R de Almeida, Jie Su, Abdullah AlShenaiber, et al.
Pageof 29